Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ LDLR Antibody Blocking Peptide
SDP

Catalog No. NBP106709E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP106709E 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP106709E Supplier Novus Biologicals™ Supplier No. NBP106709PEP
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

0 The LDLR Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 3949
Species Human
Purification Method Peptide affinity purified
Purity Immunogen affinity purified
Accession Number P01130
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Formulation PBS, 30% glycerol
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-06709. This Peptide is Useful as a Negative Control for Western Blot. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias FH, FHC, LDL receptor, LDLCQ2, low density lipoprotein receptor, low-density lipoprotein receptor, low-density lipoprotein receptor class A domain-containing protein 3
Gene Symbol LDLR
Product Type LDL R
Quantity 0.1 mL
Regulatory Status RUO - research use only
Termination Synthetic peptide made to an internal portion of the human protein (within residues 500-550) [Swiss-Prot# P01130]
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.